WHO regional director talks health care issues in the Middle East


A brand new report from the World Health Organization (WHO) and World Bank Group reveals that since 2000, most nations have made progress in increasing health service protection and lowering the monetary hardship related to health prices.

However, the poorest populations proceed to bear the biggest burden of unaffordable health prices, and an estimated 4.6 billion individuals nonetheless lack entry to important health care companies.

At the Doha Forum, in Qatar, an annual assembly of world coverage leaders, NCS spoke to Dr. Hanan Balkhy, WHO’s regional director for the Eastern Mediterranean area, the place battle and financial instability pose main health care challenges.

The following interview has been edited for size and readability.

NCS: What are the most pressing gaps you see in constructing resilient health care methods throughout the Middle East?

Hanan Balkhy: The Eastern Mediterranean area hosts 750 million individuals, together with 42% of the globally displaced inhabitants and a lot of migrants. There are additionally a major variety of nations which might be beneath sanctions or are in appreciable financial fragility or battle.

It’s been very troublesome for us to deliver these nations again from what Covid-19 has imposed on them economically and on the health sector.

But the sector in the area additionally suffers different issues, like the migration of the health workforce, lack of easy accessibility to health care, and the stockout of very vital medicines and blood merchandise. We even have issues coping with issues like gender-based violence and psychological health issues.

So, the health sector is already fragile. Covid-19 put extra stress on this health sector and likewise the sanctions, the conflicts, the wars, the displacement, makes it a really difficult area to work for.

NCS: What does the WHO’s position appear to be in right this moment’s political local weather on a regional and world scale?

Balkhy: The WHO is seen as the heart of world health in terms of setting requirements, pointers, and harmonizing the manner we follow drugs for the greatest of individuals. It ensures that the minimal that’s wanted for all populations is supplied, and that nobody is left behind. The WHO will proceed to play that position.

We have a membership of 194 member states. We work with them aspect by aspect, and hand-in-hand with governments and nongovernmental organizations. Our position is to maintain the negotiations and discussions alive so we will at all times discover methods to achieve the individuals in want.

Also, we’ve got a giant position to play in making certain that illnesses don’t unfold, by figuring out outbreaks, notifying on them, and making ready nations to reply. We additionally assist member states get rid of illnesses. The final two nations that haven’t eradicated polio but are in my area — Pakistan and Afghanistan. We’re working very laborious in direction of that purpose, with companions like the Gates Foundation, Rotary International, and different UN businesses.

NCS: What does truthful and equal entry to medical therapy appear to be in the Middle East?

Balkhy: The drawback with entry may be very advanced as a result of it means making medical merchandise protected and reasonably priced to individuals but additionally making certain that individuals can get to health care amenities, and that these amenities are outfitted with succesful health care suppliers who’ve the proper instruments.

The burden of lack of entry is giant in the Eastern Mediterranean area, due to the giant numbers of displaced populations, the giant variety of nations which might be beneath sanctions or financial fragility, and likewise the giant variety of migrants.

So, what we’re making an attempt to do now’s guarantee that the area may be self-sufficient from nation to nation. We’re making certain that governments have succesful regulatory authorities, and that they’re able to be in dialogue with one another and focus on how they create a technique for drug and medical gear manufacturing.

NCS: What is one public health concern you imagine the world will not be paying sufficient consideration to?

Balkhy: I hope that the world will actually come collectively extra robustly on issues of health in normal. As somebody who has served in health for 25 years, I really feel that the entire agenda of public health has not taken up sufficient constant house. It’s normally solely in response to a significant catastrophe, like the Covid pandemic.

But if we take into consideration health as an funding for a more healthy way of life, and for extra productive communities that may assist the financial system, I believe prioritizing the public health agenda can actually serve member states in their capacity to thrive and be self-sufficient.



Sources